Skip to main content
Clinical Trials/NCT05645731
NCT05645731
Completed
Not Applicable

Lung Cancer Screening in Family Members and Peers of Lung Cancer Patients: a Prospective Cohort Study

Nicole Ezer, MD, FRCPC, MPH1 site in 1 country100 target enrollmentMay 12, 2023

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Lung Cancer
Sponsor
Nicole Ezer, MD, FRCPC, MPH
Enrollment
100
Locations
1
Primary Endpoint
Mean number of referrals for lung cancer screening per participants
Status
Completed
Last Updated
8 months ago

Overview

Brief Summary

Lung cancer screening of active or former heavy smokers with yearly low-dose CT allows for earlier diagnosis and better lung cancer survival. Risk of developing lung cancer is higher among family members and close contacts of lung cancer patients, because of shared genetics, environment and life habits like smoking. The investigators want to engage lung cancer patients to refer their family members and close contacts for lung cancer screening, and evaluate if this referred population have higher risk of lung cancer than the population referred by their family doctors.

Registry
clinicaltrials.gov
Start Date
May 12, 2023
End Date
April 1, 2025
Last Updated
8 months ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Nicole Ezer, MD, FRCPC, MPH
Responsible Party
Sponsor Investigator
Principal Investigator

Nicole Ezer, MD, FRCPC, MPH

Assistant professor of medicine

McGill University Health Centre/Research Institute of the McGill University Health Centre

Eligibility Criteria

Inclusion Criteria

  • \> 18 years old
  • Current or former lung cancer patient

Exclusion Criteria

  • Referred participants Inclusion criteria: \>18 years old Exclusion criteria: Personal history of lung cancer.

Outcomes

Primary Outcomes

Mean number of referrals for lung cancer screening per participants

Time Frame: 2 weeks post inclusion

Mean number of referrals for lung cancer screening per participants: lung cancer participants will refer contacts directly on the REDCap questionnaire at enrollment. They will be contacted a second time 2 weeks after enrollment and asked if they referred additional people in their entourage for lung cancer screening.

Mean PLCOm2012 risk prediction model score among referred participants

Time Frame: baseline

Mean risk of developing lung cancer in the next 6 years using the validated PLCOm2012 risk prediction model in smokers or ex-smokers referred participants that are 55 to 74 years old.

Secondary Outcomes

  • Number of visitors on our website for referred participants(6 months)
  • Number of people who started to fill the enrollment form for referred participants.(6 months)
  • PLCO score as a binary outcome (above or below 2%) among referred participants(baseline)
  • Number of referred participants who enrolled in the study.(6 months)
  • Proportion of LCS eligible participants who will complete lung cancer screening within 18 months of referral by a lung cancer patient(18 months)
  • Proportion of individuals who would theoretically demonstrate interest in genetic testing to assess for lung cancer risk.(baseline)
  • Proportion of individuals who demonstrate interest in referral to a smoking cessation program among referred participants that are current smokers(baseline)
  • Anxiety regarding lung cancer for referred participants(1 month)

Study Sites (1)

Loading locations...

Similar Trials